We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
FRM
151
Fox Run Management
Connecticut
$425K +$386K +33,724 New
KK
152
KLP Kapitalforvaltning
Norway
$422K -$41.2K -3,600 -10%
QT
153
Quantbot Technologies
New York
$417K -$1.35M -118,390 -78%
Carson Wealth (CWM LLC)
154
Carson Wealth (CWM LLC)
Nebraska
$404K +$32.5K +2,840 +10%
Janney Montgomery Scott
155
Janney Montgomery Scott
Pennsylvania
$386K +$85.5K +7,477 +32%
Pictet Asset Management
156
Pictet Asset Management
Switzerland
$361K +$47.9K +4,185 +17%
OQS
157
Occudo Quantitative Strategies
Florida
$354K +$322K +28,112 New
Corient Private Wealth
158
Corient Private Wealth
Florida
$348K +$316K +27,656 New
QCM
159
Quantinno Capital Management
New York
$342K +$51K +4,460 +20%
VOYA Investment Management
160
VOYA Investment Management
Georgia
$340K -$4.64K -406 -1%
Truist Financial
161
Truist Financial
North Carolina
$323K +$137K +11,944 +87%
Aviva
162
Aviva
United Kingdom
$316K +$287K +25,078 New
M&T Bank
163
M&T Bank
New York
$296K +$269K +23,527 New
PA
164
Profund Advisors
Maryland
$294K -$5.28K -461 -2%
Teacher Retirement System of Texas
165
Teacher Retirement System of Texas
Texas
$292K -$174K -15,233 -40%
AWP
166
Abacus Wealth Partners
California
$288K +$262K +22,866 New
XT
167
XTX Topco
Cayman Islands
$275K +$249K +21,794 New
GCP
168
GSA Capital Partners
United Kingdom
$273K -$445K -38,893 -64%
Cetera Investment Advisers
169
Cetera Investment Advisers
Illinois
$270K +$78.7K +6,875 +47%
DC
170
Diametric Capital
Massachusetts
$257K -$317K -27,716 -58%
SLAM
171
Swiss Life Asset Management
$254K +$231K +20,167 New
MFS
172
Mirabella Financial Services
United Kingdom
$253K +$62.3K +5,445 +37%
Public Employees Retirement Association of Colorado
173
Public Employees Retirement Association of Colorado
Colorado
$250K – – –
GAM
174
Gotham Asset Management
New York
$246K -$70.2K -6,137 -24%
AHL
175
Abel Hall LLC
Louisiana
$243K +$221K +19,302 New
5 6
7
8 9

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.